Clinical Trial Update: Stromal Vascular Fraction (SVF) for Knee Post-Trauma Osteoarthritis (PTOA) [EARLY_Phase 1]

View source ↗

Summary

The EARLY Phase 1 trial evaluating Stromal Vascular Fraction for knee post-trauma osteoarthritis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Post-traumatic Osteoarthritis

Drugs mentioned

• Stromal Vascular Fraction (SVF) injection (stromal vascular fraction)

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Osteoarthritis | EARLY_Phase 1 | Status: WITHDRAWN